With its $58.25 Million Series B Funding, Utah-based Xenter Plans a Diagnostics Business Launch and Continued Work on Advancing AI-Empowered Medical Devices
EXECUTIVE SUMMARY
✅ Draper-based Xenter has raised $58.25 million in Series B funding, apparently the largest Life Sciences disclosed funding by a Utah-headquartered firm so far in 2026.
✅ The company plans to use the capital to commercially launch Xenter Diagnostics, while continuing development of its investigational medical devices